Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that work to expand its primary packaging capabilities at its clinical facility […]
GE Healthcare today announced the opening of a biotechnology manufacturing center at the Stevenage Bioscience Catalyst (SBC) Open Innovation Campus, in Stevenage, UK. In the first half of 2019, the center will start producing a […]
Vineti has entered into a new partnership with Tessa Therapeutics to advance and scale personalized cell therapies for solid tumors in Asia and world-wide. Tessa Therapeutics (Tessa), an international clinical stage biopharmaceutical company focusing on […]
Contract research organization (CRO) QPS has expanded its US-based phase I clinical trial capabilities to support the increasing requirements of its pharmaceutical, biotechnology and CRO partners. To fill their drug pipelines, large pharmaceutical and biotechnology […]
Biopharmaceutical company Poxel has stared part 2 of the phase 1a study for PXL065, a deuterium-stabilized R-stereoisomer of pioglitazone. This second part of the Phase 1a study will enroll six healthy subjects per group, with […]